Osteogenesis imperfecta
Synonyms: OI · Brittle bone disease · Glass bone disease · Lobstein disease
- Type
- Disease
- Group
- Disorder
- Inheritance
- Autosomal dominant, Autosomal recessive, X-linked recessive
- Age of onset
- All ages
- Status
- active
A rare, genetic, primary bone dysplasias characterized by increased bone fragility, low bone mass, and susceptibility to bone fractures. The clinical severity is heterogeneous.
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | Osteogenesis imperfecta | OI · Brittle bone disease · Glass bone disease · Lobstein disease |
| fr | Ostéogenèse imparfaite | Maladie de Lobstein · Maladie des os de verre · OI |
| de | Osteogenesis imperfecta | Glasknochenkrankheit · Lobstein-Krankheit · OI · Porak-Durante-Krankheit |
| es | Osteogénesis imperfecta | Enfermedad de Lobstein · Enfermedad de los huesos de cristal · OI |
| it | Osteogenesi imperfetta | Malattia delle ossa di vetro · Malattia delle ossa fragili · Malattia di Lobstein · OI |
| nl | Osteogenesis imperfecta | Brozebottenziekte · Glazenbottenziekte · OI · Ziekte van Lobstein |
| pt | Osteogenesis imperfecta | Doença de Lobstein · Doença dos ossos Brittle · Doença dos ossos de vidro · Doença dos ossos quebradiços · OI · Osteogénese imperfeita |
| pl | Wrodzona łamliwość kości | Choroba szklanych kości · Osteopsathyrosis · Choroba kruchych kości · Choroba Lobsteina · Choroba Poraka i Durante · OI |
| cs | Osteogenesis imperfecta | Lobsteinova nemoc · OI · Osteopsathyrosis · Porakova a Durantova nemoc · Nemoc křehkých kostí · Nemoc skleněných kostí |
| uk | Недосконалий остеогенез | Захворювання крихких кісток · Хвороба скляної кістки · Хвороба Лобштейна · OI |
| zh | 成骨不全 | Porak和Durante病 |
| tr | Osteogenezis imperfekta | OI · Lobstein hastalığı · Osteopsatiroz · Cam kemik hastalığı · Kırılgan kemik hastalığı · Porak ve Durante hastalığı |
Definition in:
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| OMIM | 166200 | BTNT | validated | |
| OMIM | 166210 | BTNT | validated | |
| OMIM | 166220 | BTNT | validated | |
| OMIM | 166230 | BTNT | validated | |
| OMIM | 259420 | BTNT | validated | |
| OMIM | 259440 | BTNT | validated | |
| OMIM | 301014 | BTNT | validated | |
| OMIM | 610682 | BTNT | validated | |
| OMIM | 610915 | BTNT | validated | |
| OMIM | 610967 | BTNT | validated | |
| OMIM | 610968 | BTNT | validated | |
| OMIM | 613848 | BTNT | validated | |
| OMIM | 613849 | BTNT | validated | |
| OMIM | 613982 | BTNT | validated | |
| OMIM | 614856 | BTNT | validated | |
| OMIM | 615066 | BTNT | validated | |
| OMIM | 615220 | BTNT | validated | |
| OMIM | 616229 | BTNT | validated | |
| OMIM | 616507 | BTNT | validated | |
| OMIM | 619131 | BTNT | validated | |
| OMIM | 619795 | BTNT | validated | |
| ICD-10 | Q78.0 | E | specific | validated |
| ICD-11 | LD24.K0 | E | specific | validated |
| MONDO | 0019019 | E | validated | |
| MeSH | D010013 | E | validated | |
| UMLS | C0029434 | E | validated | |
| GARD | 1017 | E | validated | |
| MedDRA | 10031243 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (1):
- ORPHA:93446Primary bone dysplasia with decreased bone density
rare developmental anomalies during embryogenesis; rare genetic diseases; rare bone diseases
Genes
0 direct · 36 via subtypesOrphanet records no gene directly on this code.
Recorded by Orphanet on subtypes of this disorder:
| Gene | Subtype | Association | Status | HGNC | Ensembl | OMIM | Locus | Name | Source of validation |
|---|---|---|---|---|---|---|---|---|---|
| MBTPS2 | ORPHA:216796Osteogenesis imperfecta type 1 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:15455 | ENSG00000012174 | 300294 | Xp22.12 | membrane bound transcription factor peptidase, site 2 | 27380894[PMID] |
| MESD | ORPHA:216804Osteogenesis imperfecta type 2 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:13520 | ENSG00000117899 | 607783 | 15q25.1 | mesoderm development LRP chaperone | 33596325[PMID]_31564437[PMID] |
| TENT5A | ORPHA:216812Osteogenesis imperfecta type 3 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:18345 | ENSG00000112773 | 611357 | 6q14.1 | terminal nucleotidyltransferase 5A | 29358272[PMID] |
| WNT1 | ORPHA:216812Osteogenesis imperfecta type 3 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:12774 | ENSG00000125084 | 164820 | 12q13.12 | Wnt family member 1 | 23499310[PMID]_25046257[PMID] |
| WNT1 | ORPHA:216820Osteogenesis imperfecta type 4 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:12774 | ENSG00000125084 | 164820 | 12q13.12 | Wnt family member 1 | 23434763[PMID]_25046257[PMID] |
| BMP1 | ORPHA:216812Osteogenesis imperfecta type 3 | Disease-causing germline mutation(s) in | Assessed | HGNC:1067 | ENSG00000168487 | 112264 | 8p21.3 | bone morphogenetic protein 1 | 22052668[PMID] |
| COL1A1 | ORPHA:216796Osteogenesis imperfecta type 1 | Disease-causing germline mutation(s) in | Assessed | HGNC:2197 | ENSG00000108821 | 120150 | 17q21.33 | collagen type I alpha 1 chain | 21438135[PMID]_20301472[PMID] |
| COL1A1 | ORPHA:216804Osteogenesis imperfecta type 2 | Disease-causing germline mutation(s) in | Assessed | HGNC:2197 | ENSG00000108821 | 120150 | 17q21.33 | collagen type I alpha 1 chain | 21438135[PMID]_20301472[PMID] |
| COL1A1 | ORPHA:216812Osteogenesis imperfecta type 3 | Disease-causing germline mutation(s) in | Assessed | HGNC:2197 | ENSG00000108821 | 120150 | 17q21.33 | collagen type I alpha 1 chain | 21438135[PMID]_20301472[PMID] |
| COL1A1 | ORPHA:216820Osteogenesis imperfecta type 4 | Disease-causing germline mutation(s) in | Assessed | HGNC:2197 | ENSG00000108821 | 120150 | 17q21.33 | collagen type I alpha 1 chain | 21438135[PMID]_20301472[PMID] |
| COL1A2 | ORPHA:216796Osteogenesis imperfecta type 1 | Disease-causing germline mutation(s) in | Assessed | HGNC:2198 | ENSG00000164692 | 120160 | 7q21.3 | collagen type I alpha 2 chain | 21438135[PMID]_20301472[PMID] |
| COL1A2 | ORPHA:216804Osteogenesis imperfecta type 2 | Disease-causing germline mutation(s) in | Assessed | HGNC:2198 | ENSG00000164692 | 120160 | 7q21.3 | collagen type I alpha 2 chain | 21438135[PMID]_20301472[PMID] |
| COL1A2 | ORPHA:216812Osteogenesis imperfecta type 3 | Disease-causing germline mutation(s) in | Assessed | HGNC:2198 | ENSG00000164692 | 120160 | 7q21.3 | collagen type I alpha 2 chain | 21438135[PMID]_20301472[PMID] |
| COL1A2 | ORPHA:216820Osteogenesis imperfecta type 4 | Disease-causing germline mutation(s) in | Assessed | HGNC:2198 | ENSG00000164692 | 120160 | 7q21.3 | collagen type I alpha 2 chain | 21438135[PMID]_20301472[PMID] |
| CREB3L1 | ORPHA:216812Osteogenesis imperfecta type 3 | Disease-causing germline mutation(s) in | Assessed | HGNC:18856 | ENSG00000157613 | 616215 | 11p11.2 | cAMP responsive element binding protein 3 like 1 | 24079343[PMID] |
| CRTAP | ORPHA:216804Osteogenesis imperfecta type 2 | Disease-causing germline mutation(s) in | Assessed | HGNC:2379 | ENSG00000170275 | 605497 | 3p22.3 | cartilage associated protein | 21438135[PMID] |
| CRTAP | ORPHA:216812Osteogenesis imperfecta type 3 | Disease-causing germline mutation(s) in | Assessed | HGNC:2379 | ENSG00000170275 | 605497 | 3p22.3 | cartilage associated protein | 21438135[PMID] |
| CRTAP | ORPHA:216820Osteogenesis imperfecta type 4 | Disease-causing germline mutation(s) in | Assessed | HGNC:2379 | ENSG00000170275 | 605497 | 3p22.3 | cartilage associated protein | 21438135[PMID] |
| FKBP10 | ORPHA:216812Osteogenesis imperfecta type 3 | Disease-causing germline mutation(s) in | Assessed | HGNC:18169 | ENSG00000141756 | 607063 | 17q21.2 | FKBP prolyl isomerase 10 | 21438135[PMID]_25046257[PMID] |
| FKBP10 | ORPHA:216820Osteogenesis imperfecta type 4 | Disease-causing germline mutation(s) in | Assessed | HGNC:18169 | ENSG00000141756 | 607063 | 17q21.2 | FKBP prolyl isomerase 10 | 21438135[PMID]_25046257[PMID] |
| IFITM5 | ORPHA:216828Osteogenesis imperfecta type 5 | Disease-causing germline mutation(s) in | Assessed | HGNC:16644 | ENSG00000206013 | 614757 | 11p15.5 | interferon induced transmembrane protein 5 | 22863190[PMID]_22863195[PMID]_25046257[PMID] |
| MBTPS2 | ORPHA:216812Osteogenesis imperfecta type 3 | Disease-causing germline mutation(s) in | Assessed | HGNC:15455 | ENSG00000012174 | 300294 | Xp22.12 | membrane bound transcription factor peptidase, site 2 | 27380894[PMID] |
| MBTPS2 | ORPHA:216820Osteogenesis imperfecta type 4 | Disease-causing germline mutation(s) in | Assessed | HGNC:15455 | ENSG00000012174 | 300294 | Xp22.12 | membrane bound transcription factor peptidase, site 2 | 27380894[PMID] |
| P3H1 | ORPHA:216804Osteogenesis imperfecta type 2 | Disease-causing germline mutation(s) in | Assessed | HGNC:19316 | ENSG00000117385 | 610339 | 1p34.2 | prolyl 3-hydroxylase 1 | 21438135[PMID] |
| P3H1 | ORPHA:216812Osteogenesis imperfecta type 3 | Disease-causing germline mutation(s) in | Assessed | HGNC:19316 | ENSG00000117385 | 610339 | 1p34.2 | prolyl 3-hydroxylase 1 | 21438135[PMID] |
| P4HB | ORPHA:216796Osteogenesis imperfecta type 1 | Disease-causing germline mutation(s) in | Assessed | HGNC:8548 | ENSG00000185624 | 176790 | 17q25.3 | prolyl 4-hydroxylase subunit beta | 30913006[PMID]_30948499[PMID] |
| PPIB | ORPHA:216804Osteogenesis imperfecta type 2 | Disease-causing germline mutation(s) in | Assessed | HGNC:9255 | ENSG00000166794 | 123841 | 15q22.31 | peptidylprolyl isomerase B | 21438135[PMID] |
| PPIB | ORPHA:216812Osteogenesis imperfecta type 3 | Disease-causing germline mutation(s) in | Assessed | HGNC:9255 | ENSG00000166794 | 123841 | 15q22.31 | peptidylprolyl isomerase B | 21438135[PMID] |
| PPIB | ORPHA:216820Osteogenesis imperfecta type 4 | Disease-causing germline mutation(s) in | Assessed | HGNC:9255 | ENSG00000166794 | 123841 | 15q22.31 | peptidylprolyl isomerase B | 21282188[PMID] |
| SEC24D | ORPHA:216796Osteogenesis imperfecta type 1 | Disease-causing germline mutation(s) in | Assessed | HGNC:10706 | ENSG00000150961 | 607186 | 4q26 | SEC24 homolog D, COPII component | 25683121[PMID] |
| SERPINF1 | ORPHA:216812Osteogenesis imperfecta type 3 | Disease-causing germline mutation(s) in | Assessed | HGNC:8824 | ENSG00000132386 | 172860 | 17p13.3 | serpin family F member 1 | 21353196[PMID]_25046257[PMID] |
| SERPINF1 | ORPHA:216820Osteogenesis imperfecta type 4 | Disease-causing germline mutation(s) in | Assessed | HGNC:8824 | ENSG00000132386 | 172860 | 17p13.3 | serpin family F member 1 | 25046257[PMID] |
| SERPINH1 | ORPHA:216812Osteogenesis imperfecta type 3 | Disease-causing germline mutation(s) in | Assessed | HGNC:1546 | ENSG00000149257 | 600943 | 11q13.5 | serpin family H member 1 | 21438135[PMID] |
| SP7 | ORPHA:216820Osteogenesis imperfecta type 4 | Disease-causing germline mutation(s) in | Assessed | HGNC:17321 | ENSG00000170374 | 606633 | 12q13.13 | Sp7 transcription factor | 21438135[PMID] |
| SPARC | ORPHA:216820Osteogenesis imperfecta type 4 | Disease-causing germline mutation(s) in | Assessed | HGNC:11219 | ENSG00000113140 | 182120 | 5q33.1 | secreted protein acidic and cysteine rich | 26027498[PMID] |
| TMEM38B | ORPHA:216820Osteogenesis imperfecta type 4 | Disease-causing germline mutation(s) in | Assessed | HGNC:25535 | ENSG00000095209 | 611236 | 9q31.2 | transmembrane protein 38B | 23313006[PMID]_25046257[PMID] |
Prevalence and incidence
7 records| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Point prevalence | 1-5 / 10 000 | 8.06 / 100 000 | Worldwide | Value and class | Validated | 31769437[PMID]_25944380[PMID]_24715559[PMID] |
| Prevalence at birth | 1-9 / 100 000 | 6.4 / 100 000 | France | Value and class | Validated | 2785882[PMID] |
| Prevalence at birth | 1-9 / 1 000 000 | 0.4 / 100 000 | Latin America | Value and class | Validated | 3746832[PMID] |
| Prevalence at birth | 1-9 / 100 000 | 1.5 / 100 000 | Ireland | Value and class | Validated | 22375084[PMID] |
| Prevalence at birth | 1-9 / 100 000 | 6.95 / 100 000 | United States | Value and class | Validated | 22461456[PMID]_24715559[PMID] |
| Prevalence at birth | 1-9 / 100 000 | 7.4 / 100 000 | Sweden | Value and class | Validated | 25944380[PMID] |
| Point prevalence | 1-9 / 1 000 000 | 0.375 / 100 000 | China | Value and class | Validated | 34103049[PMID] |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
HPO phenotypes
114 annotations · validated 2020-04-08| HPO | Term (as annotated by Orphanet) | Diagnostic |
|---|---|---|
| Very frequent (99-80%) | ||
| HP:0000944 | Abnormal metaphysis morphology | |
| HP:0000772 | Abnormal rib morphology | |
| HP:0011073 | Abnormality of dental color | |
| HP:0000682 | Abnormality of dental enamel | |
| HP:0002992 | Abnormality of tibia morphology | |
| HP:0000248 | Brachycephaly | |
| HP:0000670 | Carious teeth | |
| HP:0000444 | Convex nasal ridge | |
| HP:0004331 | Decreased skull ossification | |
| HP:0005019 | Diaphyseal thickening | |
| HP:0001288 | Gait disturbance | |
| HP:0000365 | Hearing impairment | |
| HP:0001511 | Intrauterine growth retardation | |
| HP:0000256 | Macrocephaly | |
| HP:0000347 | Micrognathia | |
| HP:0000410 | Mixed hearing impairment | |
| HP:0000768 | Pectus carinatum | |
| HP:0000269 | Prominent occiput | |
| HP:0000883 | Thin ribs | |
| Frequent (79-30%) | ||
| HP:0030680 | Abnormal cardiovascular system morphology | |
| HP:0003103 | Abnormal cortical bone morphology | |
| HP:0003312 | Abnormal form of the vertebral bodies | |
| HP:0002823 | Abnormality of femur morphology | |
| HP:0011314 | Abnormality of long bone morphology | |
| HP:0000164 | Abnormality of the dentition | |
| HP:0003272 | Abnormality of the hip bone | |
| HP:0000739 | Anxiety | |
| HP:0004586 | Biconcave vertebral bodies | |
| HP:0000592 | Blue sclerae | |
| HP:0002653 | Bone pain | |
| HP:0007957 | Corneal opacity | |
| HP:0000973 | Cutis laxa | |
| HP:0000689 | Dental malocclusion | |
| HP:0000703 | Dentinogenesis imperfecta | |
| HP:0004621 | Enlarged vertebral pedicles | |
| HP:0003546 | Exercise intolerance | |
| HP:0012378 | Fatigue | |
| HP:0002980 | Femoral bowing | |
| HP:0003084 | Fractures of the long bones | |
| HP:0002857 | Genu valgum | |
| HP:0000501 | Glaucoma | |
| HP:0002150 | Hypercalciuria | |
| HP:0000975 | Hyperhidrosis | |
| HP:0002659 | Increased susceptibility to fractures | |
| HP:0001382 | Joint hypermobility | |
| HP:0001382 | Joint hypermobility | |
| HP:0000239 | Large fontanelles | |
| HP:0002505 | Loss of ambulation | |
| HP:0006640 | Multiple ribs fractures | |
| HP:0000774 | Narrow chest | |
| HP:0000938 | Osteopenia | |
| HP:0000939 | Osteoporosis | |
| HP:0001730 | Progressive hearing impairment | |
| HP:0002757 | Recurrent fractures | |
| HP:0004349 | Reduced bone mineral density | |
| HP:0004322 | Short stature | |
| HP:0003100 | Slender long bone | |
| HP:0002953 | Vertebral compression fracture | |
| HP:0000505 | Visual impairment | |
| Occasional (29-5%) | ||
| HP:0004306 | Abnormality of the endocardium | |
| HP:0002829 | Arthralgia | |
| HP:0006487 | Bowing of the long bones | |
| HP:0000978 | Bruising susceptibility | |
| HP:0030267 | Calcification of the interosseus membrane of the forearm | |
| HP:0002019 | Constipation | |
| HP:0000684 | Delayed eruption of teeth | |
| HP:0003083 | Dislocated radial head | |
| HP:0002015 | Dysphagia | |
| HP:0001371 | Flexion contracture | |
| HP:0001510 | Growth delay | |
| HP:0030268 | Hyperplastic callus formation | |
| HP:0000023 | Inguinal hernia | |
| HP:0005214 | Intestinal obstruction | |
| HP:0002808 | Kyphosis | |
| HP:0002983 | Micromelia | |
| HP:0002011 | Morphological central nervous system abnormality | |
| HP:0000787 | Nephrolithiasis | |
| HP:0002758 | Osteoarthritis | |
| HP:0003401 | Paresthesia | |
| HP:0000767 | Pectus excavatum | |
| HP:0003179 | Protrusio acetabuli | |
| HP:0004482 | Relative macrocephaly | |
| HP:0002650 | Scoliosis | |
| HP:0001518 | Small for gestational age | |
| HP:0003474 | Somatic sensory dysfunction | |
| HP:0001873 | Thrombocytopenia | |
| HP:0000325 | Triangular face | |
| HP:0100661 | Trigeminal neuralgia | |
| HP:0001537 | Umbilical hernia | |
| HP:0002119 | Ventriculomegaly | |
| HP:0100761 | Visceral angiomatosis | |
| HP:0002645 | Wormian bones | |
| Very rare (<4-1%) | ||
| HP:0004942 | Aortic aneurysm | |
| HP:0002647 | Aortic dissection | |
| HP:0001659 | Aortic regurgitation | |
| HP:0002616 | Aortic root aneurysm | |
| HP:0005294 | Arterial dissection | |
| HP:0001251 | Ataxia | |
| HP:0012366 | Basilar invagination | |
| HP:0002512 | Brain stem compression | |
| HP:0001342 | Cerebral hemorrhage | |
| HP:0002947 | Cervical kyphosis | |
| HP:0006824 | Cranial nerve paralysis | |
| HP:0002315 | Headache | |
| HP:0000238 | Hydrocephalus | |
| HP:0001634 | Mitral valve prolapse | |
| HP:0002643 | Neonatal respiratory distress | |
| HP:0010953 | Noncommunicating hydrocephalus | |
| HP:0000639 | Nystagmus | |
| HP:0002089 | Pulmonary hypoplasia | |
| HP:0008905 | Rhizomelia | |
| HP:0003396 | Syringomyelia | |
| HP:0002273 | Tetraparesis | |
| HP:0005257 | Thoracic hypoplasia | |
Run the differential on the 12 obligate / very frequent terms
Annotation source: 20301472[PMID]_25439022[PMID]_36905741[PMID]
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/666
- This record as JSON: /data/d/666.json